KIORA PHARMACEUTICALS, INC. Unbilled Receivables, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Unbilled Receivables, Current of $922.49 thousand as of 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Balance Sheet › Assets
us-gaap:UnbilledReceivablesCurrent · last filed 2019-03-01
- 2018-03-31: Unbilled Receivables, Current $922.49K.
- 2018-01-02: Unbilled Receivables, Current $116.28K.
- 2017-12-31: Unbilled Receivables, Current $0.00.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2018-03-31 | $922.49K 10-Q · filed 2018-05-11 |
| 2018-01-02 | $116.28K 10-K · filed 2019-03-01 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |